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Abstract 
Adenoid cystic carcinoma (ACC) is a rare malignant tumor that might occur in nasal cavity and paranasal sinuses. It is 
characteristic for poor prognosis, especially the solid histopathological subtype of the tumor. ACC might spread along 
nerves and fascias and it is usually diagnosed at advanced stage. Computed tomography and magnetic resonance 
imaging together with fine‑needle biopsy are the gold standards in the diagnostic procedure of the cancer. Surgery 
with adjuvant therapy are the most common methods of treatment. Among the surgical approaches, the functional 
endonasal sinus surgery seems to be the most appropriate and favorable way of treatment. In the study, the authors 
present a case of a 62‑year‑old patient with T4aN0M0 ACC tumor treated endoscopically at the Department of Lar‑
yngology and ENT Oncology, WSS No. 5 in Sosnowiec. The authors indicate the usefulness of FESS procedure in the 
treatment of malignancies of nasal cavity and paranasal sinuses. They also review the recent publications on endo‑
nasal versus open approach in similar cases. In conclusions, the authors favor endonasal approach as a mini‑invasive 
method of surgical treatment of ACC of paranasal sinuses that results in satisfactory oncological outcome and high 
quality of patient’s life.
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Background
Adenoid cystic carcinomas (ACC) are rare malignant 
tumors that usually affect salivary glands [1]. They com-
prise about 1 % malignancies of all head and neck cancers 
and about 6–10  % of malignant salivary gland tumors 
[2]. The most common localization for ACC is subman-
dibular gland (15–30 %) or minor salivary glands (30 %). 
Involvement of nasal cavity is rare. It is much more com-
mon for maxillary sinus. ACC was first described by 
French scientists—Robin, Lorain and Laboulbène in 1853 
and 1854 [1].
Head and neck adenoid cystic carcinoma is charac-
teristic for spread along the nerves, high propensity for 
recurrence and distant metastases, which are often found 
when the first symptoms are observed [3–6]. It may 
invade the adjacent skull base by bone lysis and/or by 
perinervous and perivascular spread within the skull base 
foramina [7]. Advanced T stage reflects a poor progno-
sis for patients and 10-year survival is very low [1, 8]. It 
has been found that the histological subtype of a tumor, 
among which we can mention: tubular, cribriform, solid 
or mixed type, also influences the prognosis, giving 
advantage to solid subtype as the most malignant one [9, 
10]. Also, some recent studies have showed that expres-
sion of c-Kit mutations is associated with a significantly 
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The main symptoms include unilateral deformation of 
the nose, unilateral nasal obstruction, pain and recurrent 
epistaxis. Horner’s syndrome and unilateral sero-mucous 
otitis have been also reported [2].
Diagnosis covers ENT examination, computed tomog-
raphy and obligatorily preoperative tumor biopsy. MRI 
scans might help in assessment of tumor extension [2].
Surgical treatment, alternatively followed by conven-
tional or neutron irradiation, remains the optimal therapy 
[7]. Yet, the benefit of adjuvant radiotherapy has never 
been proved in randomized studies [12, 13]. Recently, the 
application of photodynamic therapy as adjuvant therapy 
to surgery in recurrent malignant tumors of the paranasal 
sinuses has been introduced [14]. As far as proton ther-
apy is concerned, it should be reserved for tumors with 
extensions to sphenoid bone or clivus and chemotherapy 
for palliative treatment [2, 15].
Until, the endoscopic era lateral rhinotomy with tumor 
resection seemed to be the best solution. However, it is 
authors’ firm belief that endonasal approach can be simi-
larly effective, resulting in complete removal with tumor-
free surgical margins.
The aim of the study is to present the usefulness and 
radicality of FESS (functional endonasal sinus surgery) 
procedure as a minimally invasive one at the resection 
of a malignant tumor of the nasal cavity and paranasal 
sinuses with bone destruction.
Case presentation
The authors report a case of a 62-year-old woman who 
was admitted to the Department of Neurosurgery. The 
patient presented with epistaxis for about 2  months, as 
well as nasal obstruction. Neither severe pain, nor nose 
deformation was reported. Anterior rhinoscopy showed 
the presence of tumor masses in the right nostril.
Therefore, a computed tomography (CT) of parana-
sal sinuses was performed. The examination proved the 
presence of expansive masses in the ethmoid and sphe-
noid sinuses as well as nasal cavities without infiltration 
of the anterior cranial fossa (Fig. 1). The biopsy revealed 
adenoid cystic carcinoma.
On admission to the Department the patient was alert, 
logically responding, with no signs of neurological defi-
ciencies. The patient did not suffer from blurred vision or 
diplopia. No allergies have been reported. Magnetic reso-
nance imaging was performed to evaluate the expansion 
of the tumor (Fig. 2). The TNM staging was estimated as 
T4aN0M0.
Minor leukocytemia (WBC 12.08  ×  103/μl) and ane-
mia (RBC 2.78 × 106/μl, HGB 9.2 g/dl, HCT 27.8 %) was 
reported. Other laboratory tests appeared to be normal.
FESS procedure in a team of neurosurgeon and ENT 
surgeon was performed under general anesthesia, i.e., 
TIVA (total intravenous anesthesia). Macroscopically 
a non-homogenic, cohesive, pink tumor was found. All 
the standard steps performed at FESS, such as uncinec-
tomy, ethmoidectomy, sphenoidectomy, were difficult 
to be precisely differentiated due to massive tumor that 
destroyed the anatomical landmarks of this region. The 
Fig. 1 Computed tomography of paranasal sinuses. Axial projection. 
Hipodensive masses in the posterior ethmoid and sphenoid sinuses 
with expansion to nasal cavities. Partially pneumatised ethmoid cells 
are visible
Fig. 2 Magnetic resonance imaging. Coronal projection. Tumor 
masses in the right nasal cavity and bilaterally ethmoid sinuses. The 
arrows indicate ethmoids in inflammatory state, separating the tumor 
from anterior cranial fossa
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operation was introduced with the resection of the cen-
tral parts of the tumor masses (debulking) together with 
infiltrated nasal septum and frontal wall of the sphenoid 
sinus. This maneuver enabled identification of the prob-
able starting point of the neoplasm, namely posterior 
part of nasal septum, i.e., sphenoid rostrum. Partially the 
margins of a tumor were visualized—tumor masses in 
the region of the ethmoid roof, sella turcica, clivus and 
left ethmoids bordered tissues free of cancerous cells. 
The right posterior ethmoids and lamina papyracea of 
the right orbit were more challenging in terms of defin-
ing exact margins of the tumor. Therefore, resection of all 
structures of this region, leaving bare bone of the right 
lamina papyracea was performed (Fig. 3). The bone itself 
seemed to remain unaltered. The surgeons encountered 
no difficulties in identification of ethmoid roof, left mid-
dle turbinate, sella turcica and other landmarks after ini-
tial debulking. No severe bleeding was noted. A dressing 
composed of Merocell was applicated to the nasal cavity 
for 48 h postoperatively. The histopathological examina-
tion revealed adenoid cystic carcinoma.
Postoperative period was uneventful. CT scans per-
formed after the operation showed radical resection of 
tumor masses (Fig. 4).
The patient was referred to an oncological department, 
where an adjuvant radiotherapy of total dose of 60  Gy 
was evaluated.
At a 2-month follow-up visit, no recurrent masses of a 
tumor were observed in CT (Fig. 4). The patient is regu-
larly controlled at the outpatient clinic and in the onco-
logical center.
Discussion
Lack of publications on endonasal removal of an ACC 
of paranasal sinuses itself causes problems in thorough 
discussion of the mentioned topic. Most authors pre-
sent general statistics on various malignant tumors 
treated with FESS, and few of them compare the results 
with open surgical approaches. Some publications refer 
exclusively to esthesioneuroblastoma [16–20] or mela-
noma of paranasal sinuses [20, 21]. The largest US data-
base of patients (120 cases) with malignant tumors of the 
sinonasal tract treated with endoscopic or endoscopic-
assisted resection has been reported by Hanna et al. [22].
Nevertheless, it seems that endoscopic resection of 
malignant tumors localized in nasal cavity and paranasal 
sinuses has been a matter of many controversies for the 
last several years [23].
Many authors believe that endoscopic sinus surgery 
is an effective method for sinonasal malignancies resec-
tion [23–25]. They indicate that it provides a satisfac-
tory survival rate with few side effects and better quality 
of life. In addition to excellent visualization, endoscopic 
approaches eliminate or significantly reduce the need 
for craniofacial soft-tissue dissection, skeletal disassem-
bly, and brain retraction for tumor access and resection 
[22]. Considering the fact that by performing FESS we 
avoid extensive scar that results in better esthetic effect 
and patient’s satisfaction, endonasal approach might be 
very tempting. Among open approaches Weber-Fer-
guson facial incision, midface degloving, craniotomy, 
Lynch procedure and Caldwell-Luc procedure should be Fig. 3 Intraoperative image after the resection of a tumor
Fig. 4 CT. Axial projection. State after radical resection of tumor 
masses—lack of the right superior and medial turbinate, medial wall 
of the right maxillary sinus, frontal walls of the sphenoid sinuses. Bare 
bone of the posterior part of the medial orbital wall, as mentioned in 
the text. The ethmoids that were well pneumatized before the surgi‑
cal procedure are now filled with postoperative edematous tissues
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mentioned [26, 27]. It is worth emphasizing that malig-
nant character of a tumor, advanced stage of the disease 
leading to cachexia often deteriorates the wound healing 
after open surgery, sometimes resulting in nasocutane-
ous fistulas [14]. Such situation may extremely decrease 
patient’s quality of life. Also, Suh et  al. claim that open 
surgical technique is burdened with higher risk of intra- 
and postoperative blood loss and higher rate of morbidity 
in comparison to endoscopic approach [27].
Endonasal endoscopic approach might be similarly 
to laryngological field beneficial in some neurosurgical 
operations [28–30]. For instance, Jouanneau et al. claim 
that the endonasal route represents an interesting alter-
native approach to Meckel’s cave as well as the cavernous 
sinus [31]. Also, according to Berhouma et al. endonasal 
endoscopic skull base surgery (EESBS) was initially dedi-
cated for transsphenoid resection of pituitary adenomas 
[32], while nowadays it offers much more opportunities, 
including the treatment of clival pathologies [33]. How-
ever, some authors do not favor EESBS in the resection 
of malignant skull base tumors, emphasizing that such 
approach should be limited to certain cases [34, 35].
Most scientists state that the endonasal method is 
reserved for experienced surgeons and that the pos-
sibility of its application depends on TNM staging [23]. 
According to Hanna et  al., the endoscopically treated 
tumors were usually of lower stage, i.e., T1–T2 [22]. They 
emphasize the necessity of co-operation between ENT 
surgeon and neurosurgeon [23]. They also focus on the 
role of proper adjuvant therapy, especially intensity-mod-
ulated radiation therapy (IMRT).
However, it is the matter of tumor-free margins that 
stimulates the greatest discussion upon endoscopic 
approach in the malignant tumor resection. Therefore, 
some authors claim that the only way to obtain above 
state is an open surgery with intraoperative biopsies. 
Yet, Sur et al. [36] suggest that the extension of the sur-
gical resection does not affect the overall survival. The 
authors believe that endoscopic approach enables perfect 
visualization of a tumor and its borders, leading to radi-
cal resection of a tumor. In the described case tumor tis-
sue differed from the normal mucosa to such extend that 
macroscopically the surgical margins seemed to be free 
of a tumor with high certainty.
According to Stammberger, the limitations of endo-
scopic technique result from the anatomical spread of 
the tumor, when extensive infiltration of orbit, dura/
brain and other vital structures exist [23]. The key ana-
tomical structures include internal carotid artery, optic 
nerve, cavernous sinuses, ethmoid roof [37]. Expansion 
of the tumor onto one or both cavernous sinuses is asso-
ciated with the risk of injury to one of the ocular motor 
nerves (nerves III, IV and VI) crossing the sinus. The risk 
is particularly high in the case of the abducens nerve as, 
contrary to nerves III and IV located in the lateral wall of 
the cavernous sinus, this nerve passes through the sinus 
lumen. During endoscopic procedures in a similar way 
like in the open brain surgeries, ocular motor nerves can 
be identified by means of neurophysiological monitor-
ing which protects them against an iatrogenic injury [38]. 
Nevertheless, surgical treatment of sinonasal malignan-
cies with skull base expansion might lead to vision loss 
or temporary diplopia due to edema of the medial rectus 
muscle [14].
It is also worth mentioning that in comparison to open 
surgery, such as lateral rhinotomy, the dressing used after 
FESS is much less uncomfortable for a patient, regard-
less the material used (Merocell, Merogel, Nasoporin, 
etc.). Moreover, it is applied only for 48 h and in case of 
absorbable dressing, there is no need of its slightly pain-
ful removal from nostrils at all. Also, the length of hospi-
tal stay in case of endoscopic technique is shorter and the 
recovery is faster [37, 39].
Of course the described method does not remain 
without limitations and disadvantages, among which 
we should mention cerebrospinal fluid (CSF) leak, espe-
cially in cases with tumor extension to the skull base 
cavities. It seems that very little space in the described 
anatomical region multiplies the difficulties of dural 
reconstruction [39]. However, in the era of fascial or 
mucosal grafts in combination with tissue sealants, 
specialized instrumentation (curved needles, self-tying 
suture) an adequate reconstruction for most small 
defects might be obtained [39]. It has been reported that 
pedicled nasoseptal flaps, first introduced by Hadad in 
2006 [40], reduced postoperative CSF leaks rates from 
20 % to around 4 % [41, 42]. In the described case, no 
CSF leak was reported.
Other complications may include meningitis, epiphora 
in the course of dacryocystitis, mild brain contusion or 
pneumocephalus [22]. None of teh above was observed 
in our patient.
A systemic review of the recent publications on lim-
its of endonasal endoscopic surgery in case of sinona-
sal tumors expanding to skull base region has been 
presented by Solares et al. [37]. The aspects raised in the 
study were: anatomical restrictions on surgical access 
(mentioned above), technical challenges such as dural 
reconstruction and hemostasis [37].
The authors are aware of the fact that the assessment of 
survival rate is inappropriate in such short period of time 
in above case, however, the aim of study was to empha-
size the usefulness of FESS procedure in mini-invasive 
removal of paranasal sinuses’ malignancies.
Page 5 of 6Wardas et al. Eur J Med Res  (2015) 20:97 
Conclusions
To sum up, the authors, who are experienced in both 
methods, believe that endoscopic approach in the treat-
ment of ACC of nasal and paranasal sinuses remains 
an effective mini-invasive method that in well-selected 
patients, together with adjuvant therapies, can be satis-
factorily applied, giving good results, complete removal 
of a tumor and high surviving rate. At the same time they 
emphasize the necessity of meticulous qualification to 
endonasal endoscopic surgeries, co-operation of ENT 
and neurosurgeon and the importance of application of 
novel technological facilities, such as neurophysiological 
monitoring.
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